Skip to search formSkip to main contentSkip to account menu

PLX8394

Known as: BRAF Inhibitor PLX8394 
An orally bioavailable inhibitor of serine/threonine-protein kinase B-raf (BRAF) protein with potential antineoplastic activity. BRAF inhibitor… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Heterocyclic Compounds, 2-RingSulfonamides
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Comment on: “Exploring the best treatment options for BRAF-mutant metastatic colon cancer”
2017
2017
New somatic BRAF splicing mutation in Langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with constitutive activation of the MAPKinase RAS-RAF… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)